Evaluation of a Website to Improve Depression Literacy in Adoldescents

Sponsor
Ludwig-Maximilians - University of Munich (Other)
Overall Status
Completed
CT.gov ID
NCT05300217
Collaborator
Prof. OTTO Beisheim Stiftung (Germany) (Other)
79
1
2
15.9
5

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the efficacy and acceptability of the website "ich bin alles" (https://www.ich-bin-alles.de/) to improve depression literacy (knowledge about depression, which aid the recognition, treatment or prevention of depression) in healthy adolescents. The investigators will examine whether the website improves depression literacy in healthy adolescents aged 12 to 18 years. The investigators will also assess the acceptability of the website among adolescents.

Condition or Disease Intervention/Treatment Phase
  • Other: Strategies for promoting mental health
  • Other: General information about depression
N/A

Detailed Description

Few young people with major depressive disorder seek professional treatment in time. Concerns about social stigma, confidentiality, and limited knowledge about mental health conditions, such as depression, or mental health services are some of the main barriers to seek treatment. To address these problems, we developed an evidence-based website "ich bin alles" (https://www.ich-bin-alles.de/) to improve depression literacy.

To improve depression literacy, the website provides general information about depression as psychiatric disorder in adolescents (e.g., symptoms, causes, course and treatment of depression). Furthermore, the website provides information about self-help strategies for depression and prevention of depression; i.e., strategies for promoting mental health (e.g., reducing stress, doing exercise, undertaking positive activities), which are meant to serve as an addition to professional treatments of depression or to promote mental health in adolescents.

Target groups of the website are adolescents aged 12 to 18 years seeking help for depression, as well as healthy adolescents seeking information about mental health promotion or depression. Easy access to information about depression would make early recognition of depression more likely and engage young people to seek help for depression.

Since the website targets two different groups, the investigators will evaluate the website accordingly:

Target group 1: Adolescents with a major depressive disorder (acute or remitted) Target group 2: Healthy Adolescents (no mental health condition) The current study will focus on target group 2. A study focusing on target group 1 can be found in a separately registered clinical trial on clinicaltrials.gov.

The primary aim of this study is to evaluate the efficacy and acceptability of the website "ich bin alles" (https://www.ich-bin-alles.de/) to improve depression literacy in healthy adolescents.

Study Design

Study Type:
Interventional
Actual Enrollment :
79 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants are assigned to two intervention groups in parallel for the duration of the studyParticipants are assigned to two intervention groups in parallel for the duration of the study
Masking:
Single (Participant)
Masking Description:
Participants are not aware of the assigned intervention group
Primary Purpose:
Other
Official Title:
Evaluating the Efficacy and the Acceptability of the Website "Ich Bin Alles" to Improve Depression Literacy in Adolescents
Actual Study Start Date :
Jan 4, 2021
Actual Primary Completion Date :
May 2, 2022
Actual Study Completion Date :
May 2, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group 1 - Strategies for promoting mental health

Exposure to information about strategies for promoting mental health

Other: Strategies for promoting mental health
Before starting the intervention, the participants are told that they will be shown parts of a website about depression. The participants are instructed to carefully attend to the website (e.g., to read the text precisely, to hear attentively to the podcasts and images on the website). The time window spent for the reception of each part of the website are fixed. The participants in this intervention group will only be shown parts of the website regarding strategies for promoting mental health

Experimental: Intervention Group 2 - General information about depression

Exposure to general information about depression

Other: General information about depression
Before starting the intervention, the participants are told that they will be shown parts of a website about depression. The participants are instructed to carefully attend to the website (e.g., to read the text precisely, to hear attentively to the podcasts and to view carefully the videos and images on the website). The time window spent for the reception of each part of the website are fixed. The participants in this intervention group will only be shown parts of the website regarding general information about depression

Outcome Measures

Primary Outcome Measures

  1. Depression Literacy - Strategies for promoting mental health [Pre-Test, Post-Test (within 2 hours), Follow-Up 1 (Week 2), Follow-Up 2 (Week 4)]

    This self-designed questionnaire is a self-report inventory to assess knowledge of strategies for promoting mental health (exercise, dealing with problems and stress, positive attitude, postive activities and social contacts; 27 items), with higher scores indicating more knowledge of strategies for promoting mental health. Participants will complete this self-designed questionnaire at pre-test, post-test and the two follow-ups to determine change in knowledge of strategies for promoting mental health.

  2. Depression Literacy - Depression as psychiatric disorder [Pre-Test, Post-Test (within 2 hours), Follow-Up 1 (Week 2), Follow-Up 2 (Week 4)]

    This self-designed questionnaire is a self-report inventory to assess knowledge of depression as psychiatric disorder (frequency and comorbidities, treatment, symptoms, causes and course of depression; 27 items), with higher scores indicating more knowledge of depression as psychiatric disorder. Participants will complete this self-designed questionnaire at pre-test, post-test and the two follow-ups to determine change in knowledge of depression as psychiatric disorder

Secondary Outcome Measures

  1. Visual Aesthetics of Websites Inventory Short Version (VisAWI-S) [Post-Test (within 2 hours)]

    The short version of the Visual Aesthetics of Websites Inventory (VisAWI-S) is self-report inventory to assess the evaluation of the website's design - especially the perceived visual aesthetics. Participants indicated their response to the four items (e.g., "The layout appears professionally designed") on a seven-point Likert scale (ranging from 1 "do not agree at all" to 7 "do fully agree")

  2. Overall reception of the website [Post-Test (within 2 hours)]

    The overall reception of the website as measured with a self-designed questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Intelligence quotient (IQ) of ≥ 80
Exclusion Criteria:
  • Current diagnosis of a mental disorder

  • Remitted depressive disorder

  • Insufficient knowledge of German

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Munich Munich Bayern Germany 80336

Sponsors and Collaborators

  • Ludwig-Maximilians - University of Munich
  • Prof. OTTO Beisheim Stiftung (Germany)

Investigators

  • Study Director: Gerd Schulte-Körne, Professor, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Munich

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ellen Greimel, Postdoctoral Researcher, Ludwig-Maximilians - University of Munich
ClinicalTrials.gov Identifier:
NCT05300217
Other Study ID Numbers:
  • 20115_2
First Posted:
Mar 29, 2022
Last Update Posted:
Jul 27, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ellen Greimel, Postdoctoral Researcher, Ludwig-Maximilians - University of Munich
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2022